ABSTRACT
We evaluated the effect of 0.1% Pranoprofen,a non-steroidal antiinflammatory drug, and therapeutic contact lens in the pain control after refractive surgeries.One hundred and two patients undergone PRK were subdivided into 4 groups: 27 patients treated with placebo (Group 1), 28 patients with Pranoprofen (Group 2), 30 patients with therapeutic contactlens (Group 3) and 17 patients with Pranoprofen and contact lens (Group 4). Forty-seven patients undergone LASIK were subdivided into 2 groups: 27 patients treated with placebo (Group 5) and 20 patients with Pranoprofen (Group 6). We recorded and analyzed visual analogue scale, 6 questions about pain and pain scores during postoperative 48 hours to evaluate the degree of pain. In PRK groups, analgesic effect was evident in groups using Pranoprofen (Group 2,4) compared to the groups not using the drugs (Group 1,3). The analgesic effect was augmented by the combined use of therapeutic contact lenses along with Pranoprofen (Group 4). Pranoprofen did not have an adverse effect on corneal epithelial wound healing.In LASIK groups,pain control was more effective in Pranoprofen using groups. However, it was not statistically significant. In conclusion, 0.1%Pranoprofen can be used effectively to reduce postoperative pain following PRK and LASIK procedures and the analgesic effect of the drug can be augmented by the combined use of therapeutic contact lenses.
Subject(s)
Humans , Contact Lenses , Keratomileusis, Laser In Situ , Ophthalmic Solutions , Pain, Postoperative , Refractive Surgical Procedures , Wounds and InjuriesABSTRACT
We evaluated after-cataract, capsular opacification, following combined lens removal with phacoemulsification or pars plana lensectomy, pars plana vitrectomy and primary or secondary IOL implantation on 34 eyes followed up more than 3 years.For the lens removal 23 eyes had pars plana lensectomy ad 11 eyes phacoemulsification. Nd-YAG capsulotomy is needed on 8/34 eyes(25.5%). Nd-YAG capsulotomy was performed on 3/23 eyes(13%) of pars plana lensectomy and on 5/11 eyes(45.5%) of phacoemulsification. Nd-YAG capsulotomy was performed to 7/22 eyes(31.8%) of primary IOL implantation and 1/12 eyes(8.3%) of secondary IOL implantation. Most patients had systemic vascular disease such as diabetes or hypertension.In conclusion, combined pars plana lensectomy, pars plana vitrectomy and secondary IOL implantation was the least incidence of after-cataract and side effects, so this procedure was thought to be recommended for vitreoretinal surgery.
Subject(s)
Humans , Incidence , Phacoemulsification , Vascular Diseases , Vitrectomy , Vitreoretinal SurgeryABSTRACT
Cytomegalovirus(CMV) ocular infection is one of the common ocular complications seen in immunocompromised condition, such as AIDS or organ transplant recipient receiving immunosuppressive drugs, CMV papillitis is known to be care. CMV papillitis has, however, a poor visual prognosis because the treatment is more resistant to than that of CMV retinitis. We report a case of CMV papillitis after the renal transplantation which has good result with long-term ganciclovir administration.